Altered transcription of the stem cell leukemia gene in myelofibrosis with myeloid metaplasia
Authors:
- M C Le Bousse-KerdilèsMBM C Le Bousse-Kerdilès
- A Colin-MicouinACA Colin-Micouin
- D ClayDCD Clay
- S ChevillardSCS Chevillard
- M C MartyréMMM C Martyré
- the Members of the French INSERM Research Network on Myelofibrosis Myeloid MetaplasiaTMthe Members of the French INSERM Research Network on Myelofibrosis Myeloid Metaplasia
- 26 September 2003
- journal article
- Published by Springer Nature in Leukemia
- Vol. 17 (10) , 1998-2006
Abstract
An increased number of circulating CD34+ hematopoietic progenitors with a prominent proliferation of the megakaryocytic (MK) population are the hallmarks of the myeloproliferation in myelofibrosis with myeloid metaplasia (MMM). Analyzing the potential contribution of the stem cell leukemia (SCL) gene in MMM myeloproliferation was doubly interesting for SCL is expressed both in primitive-uncommitted progenitor cells and erythroid/MK cells, its transcription differentially initiating from promoter 1b and 1a, respectively. Our results show that: (i) the expression of SCL transcript is increased in peripheral blood mononuclear cells (PBMCs) from patients; (ii) SCL gene transcription is altered in MMM CD34+ progenitor cells sorted into CD34+CD41+ and CD34+CD41- subpopulations. Actually, in patients, SCL transcription initiated at promoter 1b is restricted to primitive CD34+CD41- progenitor cells, while it is detectable in both cell subsets from healthy subjects; (iii) the full-length isoform of SCL protein is present in patients' CD34+ cells and in PBMC; in the latter the SCL-expressing cells mainly belong to the MK lineage in which its sublocalization is both nuclear and cytoplasmic, which contrasts with the sole nuclear staining observed in normal MK cells. Our demonstration of altered expression and transcription of SCL in patients' hematopoietic cells emphasizes the possible contribution of this regulatory nuclear factor to the hematopoietic dysregulation, which is a feature of myelofibrosis with myeloid metaplasia.Keywords
This publication has 40 references indexed in Scilit:
- Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasiaSpringer Seminars in Immunopathology, 2000
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Distinct Mechanisms Direct SCL/tal-1 Expression in Erythroid Cells and CD34 Positive Primitive Myeloid CellsJournal of Biological Chemistry, 1997
- Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cellsProceedings of the National Academy of Sciences, 1996
- The T Cell Leukemia Oncoprotein SCL/tal-1 Is Essential for Development of All Hematopoietic LineagesCell, 1996
- TGF-β and Megakaryocytes in the Pathogenesis of Myelofibrosis in Myeloproliferative DisordersLeukemia & Lymphoma, 1995
- Hematopoietic lineage commitment: Role of transcription factorsStem Cells, 1995
- Transforming growth factor‐β and megakaryocytes in the pathogenesis of idiopathic myelofibrosisBritish Journal of Haematology, 1994
- A third tal-1 promoter is specifically used in human T cell leukemias.Journal of Experimental Medicine, 1992
- Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasiaBritish Journal of Haematology, 1992